Stock Markets February 20, 2026

UBS Lowers Rating on BorgWarner, Cites Data Center Power Hype as Priced In

Analyst house raises price target but warns TurboCell optimism and execution risk are already embedded in the stock

By Nina Shah BWA
UBS Lowers Rating on BorgWarner, Cites Data Center Power Hype as Priced In
BWA

UBS cut its rating on BorgWarner to Sell from Neutral while increasing its price target to $55 from $49, saying investor expectations for the company's TurboCell data center power product appear elevated. The bank acknowledged BorgWarner's search for new growth amid declines in legacy lines but flagged execution, commercialization and disclosure gaps as reasons to temper upside expectations.

Key Points

  • UBS downgraded BorgWarner to Sell from Neutral while increasing the price target to $55 from $49, arguing that expectations for TurboCell are largely priced in.
  • UBS projects a 1% decline in Foundational and eProducts in 2026 and a roughly $210 million (1.5%) fall in the battery segment; TurboCell could contribute about $300 million in 2027 under an optimistic ramp.
  • UBS estimates the bullish scenario that has TurboCell reaching $1.5 billion by 2030, but expects a slower ramp to roughly half that level and believes around half of the upside is already reflected in the share price.

Overview

UBS has downgraded BorgWarner to Sell from Neutral, arguing that the market already seems to be valuing in an optimistic trajectory for the automaker-supplier's nascent data center power offering, TurboCell. At the same time, the bank nudged its price target up to $55 from $49.

Growth context and near-term outlook

UBS said it supports BorgWarner's pursuit of new revenue streams given pressures in its traditional segments. The bank's model incorporates an expected 1% decline in BorgWarner's core Foundational and eProducts business in 2026, and it anticipates the battery segment contracting by roughly $210 million, or 1.5%.

Those declines form the backdrop for the potential contribution from TurboCell. UBS noted that a scenario in which TurboCell achieves about $300 million in sales in 2027 could partly offset the shortfalls in legacy areas. Initial capacity for TurboCell is cited at 2 gigawatts, and UBS sees room for additional capacity expansion beyond that level.

Longer-term revenue assumptions and UBS expectations

Under a more bullish projection, UBS said TurboCell could scale to about $1.5 billion in revenue by 2030. However, the bank's base expectation assumes a slower ramp, roughly half of that peak amount by 2030. Even if the aggressive scenario materializes, UBS estimates that about 50% of that upside is already priced into BorgWarner's shares today. The firm calculates only around 10% additional upside in a best-case outcome, which it does not find compelling on a risk-adjusted basis given execution uncertainties.

Execution and disclosure concerns

UBS flagged several potential obstacles. TurboCell is treated as a startup effort; BorgWarner has not previously produced turbines at industrial scale, introducing execution risk tied to mass production. The company has provided limited public detail on product pricing, technical specifications and the pathway to achieving $300 million in 2027 sales, which UBS interprets as an indication that the initiative remains at an early stage.

Part of the TurboCell arrangement includes a battery component that UBS notes would not be reflected as BorgWarner revenue but would add to end-customer costs. While UBS acknowledged positives such as improved availability and shorter lead times relative to conventional turbines, it emphasized that TurboCell remains under development and has not yet been commercialized.

Valuation

The new $55 price target is derived from a multiple of 10 times UBS's estimate of 2027 earnings. UBS characterized that valuation multiple as being at the upper end of the stock's historical trading range, but said it nevertheless reflects the potential contribution of the new data center power opportunity.

Additional service commentary

Separately, a stock-screening product called ProPicks AI evaluates BorgWarner alongside thousands of other companies using more than 100 financial metrics. The service purports to use AI-driven screening to identify stocks with attractive risk-reward profiles and cited past winners such as Super Micro Computer, which it listed as +185%, and AppLovin, listed as +157%.


Impacted sectors

  • Automotive parts and suppliers
  • Data center infrastructure and power systems
  • Industrial manufacturing and energy equipment

Risks

  • Execution risk from TurboCell being treated as a startup and BorgWarner's lack of experience producing turbines at scale - affects industrial manufacturing and supplier sectors.
  • Limited company disclosure on pricing, specifications and the path to $300 million in 2027 sales, indicating the project may be at an early stage - affects investor visibility across equity markets.
  • The inclusion of a battery component that does not generate BorgWarner revenue but adds to customer costs, which could influence customer economics and adoption in data center power markets.

More from Stock Markets

Madrid Stocks Close Higher as IBEX 35 Advances 0.81% Feb 20, 2026 U.K. Shares Rise; United Kingdom 100 Reaches New Record Close Feb 20, 2026 Belgian equities slip as BEL 20 closes down 0.17% Feb 20, 2026 OMX Stockholm 30 Closes Higher, Reaches New Record High Feb 20, 2026 Helsinki index closes at record high as consumer, financial and telecom names lead gains Feb 20, 2026